| EPD495 | 'You can get that person on ART but you can't give them back their social system'. Qualitative insights of HIV voluntary assisted 'partner notification' in marginalized populations | E-poster | Prevention interventions and their effects on the lives and relationships of people living with HIV |
| EPB192 | Impact of mother mentors' model to improve retention in PMTCT services in health facilities supported by Global Funds. a case from Christian Social Services Commission (CSSC)-AMREF, Tanzania | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB193 | Associations between HIV/ART exposure during pregnancy and adverse maternal and infant outcomes in the MANGO cohort in western Kenya | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB194 | A multicentre observational study to determine the safety and effectiveness of dolutegravir (DTG) use during pregnancy: data from DOLOMITE-NEAT ID Network study | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB195 | Impact of point-of-care HIV viral load and drug resistance testing among pregnant and postpartum women living with HIV in Western Kenya: apre- and post-intervention study | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB196 | Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB197 | Adverse perinatal outcomes associated with highly active antiretroviral therapy and monotherapy in women living with HIV: a systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| OAB0405 | HIV/HBV coinfection in pregnancy and response to antiretroviral therapy | Oral abstract session with live Q&A | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| PELBB02 | Update on neural tube defects with antiretroviral exposure in the Tsepamo Study, Botswana | Poster exhibition | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| PEMOB28 | Safety outcomes among HIV-1 positive Zambian adults receiving Tenofovir Alafenamide combined with Dolutegravir: results from the VISEND clinical trial | Poster exhibition | Pregnancy (clinical management issues and pharmacokinetics) and contraception |